McKesson
MCK
#303
Rank
$52.60 B
Marketcap
$387.95
Share price
-1.88%
Change (1 day)
15.82%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

P/E ratio for McKesson (MCK)

P/E ratio as of May 2023 (TTM): 17.6

According to McKesson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.6259. At the end of 2021 the company had a P/E ratio of 27.6.

P/E ratio history for McKesson from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202127.6-526.7%
2020-6.48-77.19%
2019-28.4-65.8%
2018-83.1-1311.15%
20176.86-58.3%
201616.4-29.29%
201523.3-16.97%
201428.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
47.5 169.26%๐Ÿ‡บ๐Ÿ‡ธ USA
16.7-5.49%๐Ÿ‡บ๐Ÿ‡ธ USA
21.4 21.53%๐Ÿ‡บ๐Ÿ‡ธ USA
46.7 165.09%๐Ÿ‡บ๐Ÿ‡ธ USA
16.6-5.65%๐Ÿ‡บ๐Ÿ‡ธ USA
13.1-25.60%๐Ÿ‡บ๐Ÿ‡ธ USA
22.6 28.49%๐Ÿ‡บ๐Ÿ‡ธ USA
23.8 34.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-37.7-314.12%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.